ClinicalTrials.Veeva

Menu

Drug Burden Index is Associated With Malnutrition in Community-dwelling Dementia Patients

S

Sultan Keskin Demircan

Status

Completed

Conditions

Malnutrition Severe
Anticholinergic Toxicity
Drug Use
Dementia

Study type

Observational

Funder types

Other

Identifiers

NCT06447259
GulhaneTR2

Details and patient eligibility

About

Malnutrition leads to poor clinical outcomes in dementia patients. The investigator aimed to examine the association between drug burden index (DBI) and anticholinergic burden (ACB) scores with nutrition status in community-dwelling older adults with dementia, considering that drugs may contribute malnutrition.

A total of 415 outpatients with dementia, evaluated by Mini Nutrition Assessment test and registered drug information, are included in the study. The investigator calculated the DBI as the sum of all sedatives and anticholinergics taken continuously for at least four weeks prior to admission and evaluated the ACB score.

Practice Impact: Due to accompanying chronic diseases and symptoms, cholinergic and/or sedative-loaded drugs are often prescribed to dementia patients. In this study, İnvestigators emphasized that in addition to the cholinergic loads of the drugs used, their sedative loads and the drug doses they use are also important. Avoiding prescribing these medications to patients with dementia will protect them from malnutrition and its negative consequences.

Enrollment

415 patients

Sex

All

Ages

65 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of any type of demantia
  • Must be able to swallow tablets
  • Must be recorded data of medications and doses

Exclusion criteria

  • Psychiatric disorders
  • Mild cognitive impairment
  • End-stage diseases (renal, liver, cardiac)
  • Uncontrolled thyroid functions

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems